Effect of radiotherapy on the survival of patients with stage i and stage II mantle cell lymphoma: Analysis of the surveillance, epidemiology and end results database

Clinical Lymphoma, Myeloma and Leukemia

Volumn 14, Issue , 2014, Pages S90-S95

  Guru Murthy, Guru Subramanian ^a   Venkitachalam, Raji ^b   Mehta, Paulette ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b The Cochin College   (India)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Adults; B cell non Hodgkin lymphoma; Cyclin D1; Radiation; t(11,14)(q13; q32)

Indexed keywords

ADULT; AGED; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; OVERALL SURVIVAL; RETROSPECTIVE STUDY; CANCER REGISTRY; HEALTH SURVEY; LYMPHOMA, MANTLE-CELL; MIDDLE AGED; MORTALITY; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SEER PROGRAM; TREATMENT OUTCOME;

EID: 84939427796     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2014.04.013     Document Type: Conference Paper

References (21)

1. P.M. Banks, J. Chan, M.L. Cleary, and et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic and molecular data Am J Surg Pathol 16 1992 637 640
2. Y. Zhou, H. Wang, W. Fang, and et al. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004 Cancer 113 2008 791 798
3. K. Fu, D.D. Weisenburger, T.C. Greiner, and et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling Blood 106 2005 4315 4321
4. W. Xu, and J.Y. Li SOX11 expression in mantle cell lymphoma Leuk Lymphoma 51 2010 1962 1967
5. M. Bernard, R. Gressin, F. Lefrere, and et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype Leukemia 15 2001 1785 1791
6. R. Chandran, S.K. Gardiner, M. Simon, and S.E. Spurgeon Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007 Leuk Lymphoma 53 2012 1488 1493
7. A. Herrmann, E. Hoster, T. Zwingers, and et al. Improvement of overall survival in advanced stage mantle cell lymphoma J Clin Oncol 27 2009 511 518
8. H.A. Leitch, R.D. Gascoyne, M. Chhanabhai, N.J. Voss, R. Klasa, and J.M. Connors Limited-stage mantle-cell lymphoma Ann Oncol 14 2003 1555 1561
9. B.D. Rosenbluth, and J. Yahalom Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT) Int J Radiat Oncol Biol Phys 65 2006 1185 1191
10. M. Bernard, R.W. Tsang, L.W. Le, and et al. Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital Leuk Lymphoma 54 2013 261 267
11. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER∗Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (1973-2010 varying) - Linked To County Attributes - Total U.S., 1969-2011 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission.
12. H. Samaha, C. Dumontet, N. Ketterer, and et al. Mantle cell lymphoma: a retrospective study of 121 cases Leukemia 12 1998 1281 1287
13. E. Vandenberghe, C. Wolf-Peeters, H.G. Vaughan, and et al. The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group Br J Haematol 99 1997 842 847
14. R. M'kacher, A. Bennaceur, F. Farace, and et al. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma Oncogene 22 2003 7905 7912
15. A. Zelenetz, J.S. Abramson, J.H. Advani, and et al. NCCN Clinical Practice Guidelines in Oncology, non-Hodgkin lymphomas J Natl Compr Canc Netw 8 2010 288 334
16. P. McKay, M. Leach, R. Jackson, G. Cook, and S. Rule British Committee for Standards in Haematology. Guidelines for the investigation and management of mantle cell lymphoma Br J Haematol 159 2012 405 426
17. A. Carbone, and A. Santoro How I treat: diagnosing and managing "in situ" lymphoma Blood 117 2011 3954 3960
18. E. Hoster, M. Dreyling, W. Klapper, and et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Blood 111 2008 558 565
19. E.D. Hsi, and P. Martin Indolent mantle cell lymphoma Leuk Lymphoma 55 2014 761 767
20. A.J. Ambinder, P.J. Shenoy, L.J. Nastoupil, and C.R. Flowers Using primary site as a predictor of survival in mantle cell lymphoma Cancer 119 2013 1570 1577
21. M.R. Smith, H. Li, L. Gordon, and et al. Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90-ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group Study E1499 J Clin Oncol 30 2012 3119 3126